SUBSCRIBE
SUBSCRIBE

Maryland

FDA sign outside its office in Maryland
Regulatory
FDA Issues Final Guidance for Using Real-World Data in Drug Applications
The regulator on Wednesday provided recommendations to drugmakers for assessing the use of electronic health records and medical claims data to support their applications.
July 25, 2024
 · 
2 min read
 · 
Tristan Manalac
Biopharma collage of scientist, deals, and pills
Opinion
When Should Biopharma Companies Buy, Partner or Develop Innovative Assets?
Here’s how to assess whether to develop a new therapy by building a proprietary platform, acquiring another company or asset or partnering with an established entity.
April 24, 2024
 · 
6 min read
 · 
Anshul Mangal
Load More
PRESS RELEASES
Press Releases
Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025
July 16, 2025
 · 
1 min read
Press Releases
OncoC4 to Present at the 2025 Orphan Drug Summit on Strategies to Eliminate Anti-Drug Antibodies in Orphan Therapies
July 16, 2025
 · 
2 min read
Press Releases
Gain Therapeutics Announces Proposed Public Offering
July 16, 2025
 · 
4 min read
Press Releases
IonQ Completes Acquisition of Capella Space, Advancing Vision for Space-Based Quantum Communications
July 15, 2025
 · 
6 min read
Press Releases
Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL
July 10, 2025
 · 
11 min read
Press Releases
GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025
July 10, 2025
 · 
1 min read
Press Releases
Altimmune Announces Initiation of RESTORE Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol-Associated Liver Disease (ALD)
July 10, 2025
 · 
6 min read
Press Releases
MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025
July 10, 2025
 · 
1 min read
Press Releases
BCAN Launches $1 Million Continuity Grant to Sustain Bladder Cancer Research
July 9, 2025
 · 
1 min read
Press Releases
Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts
July 9, 2025
 · 
6 min read
Press Releases
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
July 8, 2025
 · 
7 min read
Press Releases
I-Mab Presents Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025
July 3, 2025
 · 
10 min read
Press Releases
Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate
July 3, 2025
 · 
8 min read
Press Releases
New Evidence Supports the Value of Elutia’s Antibiotic-Eluting Platform for Implantable Devices
July 2, 2025
 · 
6 min read
Press Releases
Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)
July 1, 2025
 · 
3 min read
Press Releases
I-Mab Announces Publication of Givastomig Monotherapy Data in Clinical Cancer Research
July 1, 2025
 · 
9 min read
Press Releases
Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation
June 30, 2025
 · 
7 min read
Press Releases
Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025
June 30, 2025
 · 
1 min read
Press Releases
TransThera Publishes Translational Studies of Tinengotinib (TT-00420) against Cholangiocarcinoma on Annals of Oncology
June 27, 2025
 · 
4 min read
Press Releases
Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH
June 26, 2025
 · 
12 min read
Load More